Symphogen is a biotechnology company located in Copenhagen, Denmark that develops protein drugs based on recombinant monoclonal antibody mixtures. These drugs are different from the polyclonal antibodies, as each antibody in the mixture is produced from one carefully selected clone. Their three main areas of therapeutic research are immunoglobulin replacement, cancer, and infectious diseases. The company was founded in 2000 and has patents on a drug discovery platform called Symplex and a drug manufacturing platform called Sympress. By 2009, ten drugs were being developed with rozrolimupab (Sym001) being the lead product. Laboratoires Servier acquired Symphogen in 2020. More information...
According to PR-model, symphogen.com is ranked 1,984,785th in multilingual Wikipedia, in particular this website is ranked 1,114,389th in English Wikipedia.
The website is placed before flightlessbird.tv and after klitetools.com in the BestRef global ranking of the most important sources of Wikipedia.
